| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/SUR.2016.261 |
| P698 | PubMed publication ID | 28085573 |
| P50 | author | Robert G. Sawyer | Q42844078 |
| Kevin P. Mollen | Q46962562 | ||
| Matthew R Rosengart | Q122973228 | ||
| P2093 | author name string | John E Mazuski | |
| Addison K May | |||
| Evan P Nadler | |||
| Patrick J O'Neill | |||
| Jose J Diaz | |||
| Jose M Prince | |||
| Jared M Huston | |||
| Jeffrey M Tessier | |||
| Phillip K Chang | |||
| P2860 | cites work | Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008. | Q30834974 |
| P433 | issue | 1 | |
| P304 | page(s) | 1-76 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Surgical Infections | Q15765824 |
| P1476 | title | The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection | |
| P478 | volume | 18 |
| Q56343872 | 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation |
| Q60310408 | A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China |
| Q58128689 | Antibiotic duration can be shortened in postoperative intra-abdominal infection |
| Q101121046 | Antibiotic sensitivity in correlation to the origin of secondary peritonitis: a single center analysis |
| Q91748111 | Antimicrobial Susceptibility of Microorganisms Isolated from Patients with Intraabdominal Infection in Korea: a Multicenter Study |
| Q52658663 | Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015). |
| Q90656575 | Antimicrobial therapy of 3 days or less is sufficient after successful ERCP for acute cholangitis |
| Q92135103 | Carbapenem Treatment and Outcomes Among Patients With Culture-Positive Complicated Intra-abdominal Infections in US Hospitals: A Retrospective Cohort Study |
| Q90437573 | Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections: A Bayesian network meta-analysis of randomized clinical trials |
| Q91906124 | Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy |
| Q55453592 | Clinical characteristics and prognosis of bacteraemia during postoperative intra-abdominal infections. |
| Q90353868 | Coagulative biomarkers on admission to the ICU predict acute kidney injury and mortality in patients with septic shock caused by intra-abdominal infection |
| Q90306681 | Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality |
| Q91671808 | Diagnosis and Therapeutic Management in Postcholecistectomy Alithiasic Cholangitis |
| Q92663234 | Disease burden of appendectomy for appendicitis: a population-based cohort study |
| Q49609584 | Disease-based antimicrobial stewardship: a review of active and passive approaches to patient management |
| Q40319784 | Enterococci and surgical site infections : Causal agent or harmless commensals? |
| Q64244026 | Eravacycline: A Review in Complicated Intra-Abdominal Infections |
| Q89458062 | Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis |
| Q90609929 | IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal Infections |
| Q52319392 | Interobserver variability in the classification of appendicitis during laparoscopy. |
| Q49356543 | Intra-abdominal infection combined with intra-abdominal hypertension aggravates the intestinal mucosal barrier dysfunction |
| Q90321474 | Is fixed short-course antimicrobial therapy justified for patients who are critically ill with intra-abdominal infections? |
| Q38708901 | Longer-Duration Antimicrobial Therapy Does Not Prevent Treatment Failure in High-Risk Patients with Complicated Intra-Abdominal Infections. |
| Q90271813 | Methods of conservative antibiotic treatment of acute uncomplicated appendicitis: A systematic review |
| Q64105106 | Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017) |
| Q33627283 | Risk factors and long-term outcome for postoperative intra-abdominal infection after hepatectomy for hepatocellular carcinoma |
| Q89996292 | Serum Interleukin-8 in Patients with Different Origin of Intra-Abdominal Infections in Perioperative Period |
| Q41691086 | Shifting trends in bacteriology and antimicrobial resistance among gastrointestinal fistula patients in China: an eight-year review in a tertiary-care hospital |
| Q53706279 | Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. |
| Q64101103 | The 2018 Lebanese Society of Infectious Diseases and Clinical Microbiology Guidelines for the use of antimicrobial therapy in complicated intra-abdominal infections in the era of antimicrobial resistance |
| Q60953881 | The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for |
| Q90194917 | The SIFIPAC/WSES/SICG/SIMEU guidelines for diagnosis and treatment of acute appendicitis in the elderly (2019 edition) |
| Q58777803 | The appropriateness of ceftriaxone and metronidazole as empirical therapy in managing complicated intra-abdominal infection-experience from Western Health, Australia |
| Q61805257 | The impact of initial antibiotic treatment failure: real-world insights in patients with complicated, health care-associated intra-abdominal infection |
| Q46770277 | Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. |
| Q55039125 | Top Questions in Uncomplicated, Non-Staphylococcus aureus Bacteremia. |
| Q53688845 | Two versus five days of antibiotics after appendectomy for complex acute appendicitis (APPIC): study protocol for a randomized controlled trial. |
| Q40079705 | Unmet needs in the management of intra-abdominal infections |
| Q47705849 | Update on new research in Gram-negative infections European Congress of Clinical Microbiology and Infectious Diseases 2017 (22-25 April, Vienna, Austria). |
| Q90219865 | Use of Procalcitonin to Guide Discontinuation of Antimicrobial Therapy in Patients with Persistent Intra-Abdominal Collections: A Case Series |
| Q60305533 | Vancomycin in the treatment of adult intra-abdominal infections: do we have strong evidences? |
| Q91747589 | Variation in Classification and Postoperative Management of Complex Appendicitis: A European Survey |
| Q55091146 | What every intensivist should know about the management of peritonitis in the intensive care unit. |
Search more.